BNIP3 and nasopharyngeal carcinoma: We hypothesized that FOXD1 might transcriptionally activate BNIP3 expression, thereby promoting mitophagy and malignant progression in NPC cells, potentially leading to insensitivity to chemotherapeutic drugs.